Chevron (NYSE: CVX) filer details 10b5-1 sales and 32,100-share plan

Rhea-AI Filing Summary

Chevron-related Form 144 shows a planned stock sale by a shareholder. The notice covers up to 32,100 shares of Chevron common stock to be sold on the NYSE around 01/30/2026 through Morgan Stanley Smith Barney. These shares are shown as acquired the same day via a cash exercise of stock options.

The filing also lists recent Rule 10b5-1 plan sales for Eimear Bonner, including 7,534 common shares sold on 01/28/2026 for gross proceeds of $1,280,780.00 and 28,334 shares sold on 01/05/2026 for $4,676,526.70. The filer represents they are not aware of undisclosed material adverse information about Chevron’s operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32100	5495199.00	2013521597	01/30/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/30/2026	Exercise of Stock Options	Issuer			32100	01/30/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for EIMEAR BONNER 1400 Smith Street Houston TX 77002	Common	01/28/2026	7534	1280780.00
10b5-1 Sales for EIMEAR BONNER 1400 Smith Street Houston TX 77002	Common	01/05/2026	28334	4676526.70

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Chevron (CVX) Form 144 filing disclose about share sales?

The Form 144 filing discloses a planned sale of up to 32,100 Chevron common shares on the NYSE, plus recent Rule 10b5-1 plan sales totaling 7,534 and 28,334 shares, with gross proceeds of $1,280,780.00 and $4,676,526.70.

How many Chevron (CVX) shares are planned to be sold under this Form 144?

The filing shows a planned sale of 32,100 Chevron common shares. These shares are tied to a cash exercise of stock options dated 01/30/2026, and are expected to be sold on the NYSE through Morgan Stanley Smith Barney’s Executive Financial Services group.

What recent 10b5-1 sales for Eimear Bonner in Chevron (CVX) stock are listed?

The document lists two recent 10b5-1 sales for Eimear Bonner: 7,534 common shares sold on 01/28/2026 for $1,280,780.00 and 28,334 common shares sold on 01/05/2026 for $4,676,526.70, both described as Chevron common stock transactions.

How were the Chevron (CVX) shares in the planned sale acquired?

The 32,100 Chevron common shares in the planned sale were acquired on 01/30/2026 through an exercise of stock options from the issuer. The filing states that payment for these shares was made in cash on the same date as the option exercise.

Which broker is handling the planned Chevron (CVX) share sale in this Form 144?

The planned sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services. The broker’s address is listed as 1 New York Plaza, 8th Floor, New York, NY 10004, and the shares are expected to be sold on the NYSE.

What representation does the Form 144 filer make about Chevron (CVX) information?

The filer represents that they do not know any material adverse information about Chevron’s current or prospective operations that has not been publicly disclosed, a standard affirmation included when relying on Rule 144 and, if applicable, a Rule 10b5-1 trading plan.